150 related articles for article (PubMed ID: 37545846)
1. Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging.
van Riel LAMJG; van Kollenburg RAA; Freund JE; Almasian M; Jager A; Engelbrecht MRW; Smit RS; Bekers E; Nieuwenhuijzen JA; van Leeuwen PJ; van der Poel H; de Reijke TM; Beerlage HP; Oddens JR; de Bruin DM
Eur Urol Open Sci; 2023 Aug; 54():72-79. PubMed ID: 37545846
[TBL] [Abstract][Full Text] [Related]
2. Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study.
van Riel LAMJG; van Kollenburg RAA; Vis AN; van Leeuwen PJ; de Reijke TM; de Bruin DM; Oddens JR
Eur Urol Open Sci; 2022 May; 39():48-54. PubMed ID: 35528781
[TBL] [Abstract][Full Text] [Related]
3. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
4. Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study.
Peltier A; van Velthoven R; Baudewyns A; Assenmacher G; Lemort M; Lefebvre Y; Sirtaine N; Diamand R
BJU Int; 2024 May; ():. PubMed ID: 38742416
[TBL] [Abstract][Full Text] [Related]
5. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
6. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
[TBL] [Abstract][Full Text] [Related]
7. Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer.
Manenti G; Nezzo M; Ryan CP; Fraioli FR; Carreri B; Gigliotti PE; Angeloni C; Di Pietro F; De Angeli M; Perretta T; D'Angelillo RM; Garaci FG
BJR Open; 2023; 5(1):20230042. PubMed ID: 37942495
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
[TBL] [Abstract][Full Text] [Related]
9. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
[TBL] [Abstract][Full Text] [Related]
10. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study.
van Kollenburg R; van Riel L; Bloemen P; de Reijke T; Beerlage H; de Bruin D; Oddens J
BJUI Compass; 2024 Jan; 5(1):52-59. PubMed ID: 38179027
[TBL] [Abstract][Full Text] [Related]
11. Dynamic prostatic and laser-ablated lesion volume change after transperineal laser ablation in canine: preliminary observation and its clinical significance.
Liu RQ; Liu JB; Duan SB; Cheng SG; Chang ZY; Cao HC; Cao GS; Li YQ; Li N; Zhang LZ
Int J Hyperthermia; 2020; 37(1):1260-1267. PubMed ID: 33191810
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
13. Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project.
Cocci A; Pezzoli M; Bianco F; Blefari F; Bove P; Cornud F; De Rienzo G; Destefanis P; Di Trapani D; Giacobbe A; Giovanessi L; Laganà A; Lughezzani G; Manenti G; Muto G; Patelli G; Pinzi N; Regusci S; Russo GI; Salamanca JIM; Salvi M; Silvestri L; Verweij F; Walser E; Bertolo RG; Iacovelli V; Bertaccini A; Marchiori D; Davila H; Ditonno P; Gontero P; Iapicca G; M De Reijke T; Ricapito V; Pellegrini P; Minervini A; Serni S; Sessa F
Asian J Urol; 2024 Apr; 11(2):271-279. PubMed ID: 38680587
[TBL] [Abstract][Full Text] [Related]
14. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy.
Sun C; Wang S; Chatterjee A; Medved M; Eggener S; Karczmar GS; Oto A
Eur Radiol; 2021 Jan; 31(1):325-332. PubMed ID: 32785769
[TBL] [Abstract][Full Text] [Related]
15. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
[TBL] [Abstract][Full Text] [Related]
16. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
17. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.
Bomers JGR; Cornel EB; Fütterer JJ; Jenniskens SFM; Schaafsma HE; Barentsz JO; Sedelaar JPM; Hulsbergen-van de Kaa CA; Witjes JA
World J Urol; 2017 May; 35(5):703-711. PubMed ID: 27541586
[TBL] [Abstract][Full Text] [Related]
18. Transperineal Laser Ablation (TPLA) Treatment of Focal Low-Intermediate Risk Prostate Cancer.
Manenti G; Perretta T; Nezzo M; Fraioli FR; Carreri B; Gigliotti PE; Micillo A; Malizia A; Di Giovanni D; Ryan CP; Garaci FG
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611082
[No Abstract] [Full Text] [Related]
19. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
[TBL] [Abstract][Full Text] [Related]
20. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M
Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
